Charles Schwab Investment Management Inc Wave Life Sciences Ltd. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 844,617 shares of WVE stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
844,617
Previous 273,272
209.08%
Holding current value
$10.2 Million
Previous $1.36 Million
408.07%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding WVE
# of Institutions
166Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$219 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$121 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$117 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$81.1 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$74.2 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.05B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...